[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novartis AG Graphic](https://lunarcrush.com/gi/w:26/t:novartis.png) Novartis AG (NVS)

Novartis's Kisqali 5-year NATALEE data shows a XX% reduction in the risk of recurrence in early breast cancer. CHMP backs Novartis Scemblix for newly diagnosed CML, expanding EU access.

### About Novartis AG
Novartis AG (NVS) is a global pharmaceutical company.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/novartis/insights)
- Novartis AG (NVS) social dominance is up XXXXXX% from the previous X months.
- Novartis AG (NVS) creators is up XXXXX% from the previous week.
- Novartis AG (NVS) engagements is up XXXXX% from the previous week.
- Novartis AG (NVS) mentions is up XXXXX% from the previous week.

### Price: $XXXXXX [#](/topic/novartis/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/novartis/time-series/close.tsv)  
The recent negative price action (-2.29% in the last XX days) is likely due to the pressure from the US government to lower drug prices and the impact of tariffs, as indicated by the critical themes.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXX%    | XXXX% | XXXX%  |

**1-Year High**: $XXXXXX on 2025-10-03  
**1-Year Low**: $XXXXX on 2024-12-19  
  
  
### AltRank: XXX [#](/topic/novartis/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #334 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +153  
**1 Month**: XXX -XXX  
**6 Months**: XXX +82  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-02-18  
**1-Year Low**: XX on 2025-06-12  
  
  
### Galaxy Score: XXXXX [#](/topic/novartis/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/novartis/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +3  
**1 Month**: XX +16  
**6 Months**: XX -XX  
**1 Year**: XX +19  
**1-Year High**: XX on 2025-05-20  
**1-Year Low**: XX on 2024-10-20  
  
  
### Engagements: XXXXXXX [#](/topic/novartis/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/novartis/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXXXX +88%  
**1 Month**: XXXXXXXXX -XX%  
**6 Months**: XXXXXXXXXX +81%  
**1 Year**: XXXXXXXXXX +50%  
**1-Year High**: XXXXXXXXX on 2025-08-26  
**1-Year Low**: XXXXXX on 2025-01-27  

| Social Network | Reddit | TikTok | X       | YouTube | News |
| -------------- | ------ | ------ | -       | ------- | ---- |
| Engagements    | XXXXX  | XXXXXX | XXXXXXX | XXXXXXX | XX   |
  

  
  
### Mentions: XXX [#](/topic/novartis/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/novartis/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX +13%  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXXX +45%  
**1 Year**: XXXXXX +163%  
**1-Year High**: XXX on 2025-09-09  
**1-Year Low**: XX on 2024-10-20  

| Social Network | Reddit | TikTok | X   | YouTube | News |
| -------------- | ------ | ------ | -   | ------- | ---- |
| Mentions       | XX     | XXX    | XXX | XXX     | X    |
  

  
  
### Creators: XXX [#](/topic/novartis/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/novartis/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XXXX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XXX +17%  
**1 Month**: XXXXX -XX%  
**6 Months**: XXXXX +37%  
**1 Year**: XXXXXX +181%  
**1-Year High**: XXX on 2025-09-09  
**1-Year Low**: XX on 2024-10-20  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                                      | Rank | Followers | Posts | Engagements |
| -------                                                      | ---- | --------- | ----- | ----------- |
| [@novartis](/creator/youtube/novartis)                       | X    | XXXXXX    | XX    | XXXXXXX     |
| [@ThePlayersTV](/creator/twitter/ThePlayersTV)               | X    | XXXXX     | X     | XXXXXXX     |
| [@theplayerstv](/creator/tiktok/theplayerstv)                | X    | XXXXXX    | X     | XXXXXX      |
| [@ValueSense_io](/creator/twitter/ValueSense_io)             | X    | XXXXXX    | X     | XXXXX       |
| [@Darwin_Knows](/creator/twitter/Darwin_Knows)               | X    | XXX       | XX    | XXXXX       |
| [@HealthPolicyW](/creator/twitter/HealthPolicyW)             | X    | XXXXXX    | X     | XXXXX       |
| [@nucleusmedicalmedia](/creator/youtube/nucleusmedicalmedia) | X    | XXXXXXXXX | X     | XXX         |
| [@stats_feed](/creator/twitter/stats_feed)                   | X    | XXXXXXXXX | X     | XXX         |
| [@drevanlevine](/creator/tiktok/drevanlevine)                | X    | XXXXXXX   | X     | XXX         |
| [@OmarMedawar](/creator/twitter/OmarMedawar)                 | XX   | XXX       | X     | XXX         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: XX% [#](/topic/novartis/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/novartis/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +2%  
**1 Month**: XX% -XX%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -X%  
**1-Year High**: XX% on 2024-10-20  
**1-Year Low**: XX% on 2025-08-26  

**Most Supportive Themes**
- **Positive Sentiment and Investment:** (29%) Posts highlighting positive sentiment, investment, and potential growth opportunities for Novartis.
- **Company Performance and Data:** (20%) Posts discussing Novartis's performance, new data, and advancements in oncology and other therapeutic areas.
- **Industry Recognition and Leadership:** (15%) Posts mentioning Novartis's leadership, CEO, and recognition within the pharmaceutical industry.
  
**Most Critical Themes**
- **Tariffs and Drug Pricing:** (20%)  Posts discussing the impact of US tariffs and pressure to lower drug prices.
- **Competition and Market Challenges:** (10%)  Posts about competition from other companies and market challenges.
- **Job Cuts and Layoffs:** (10%)  Posts mentioning job cuts and layoffs within the pharmaceutical industry, including Novartis.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | XXX      | X%  | XXX     | X%  | XXX      | X% |
| TikTok  | XXXXXX   | XX% | XXXXX   | X%  | XXX      | X% |
| X       | XXXXXXX  | XX% | XXXXXX  | X%  | XXX      | X% |
| YouTube | XXXXXXX  | XX% | XXXXXXX | XX% | XXX      | X% |
| News    | X        | X%  | XX      | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXXX  | XX% | XXXXXXX | XX% | XXXXX    | X% |
  

  
  
### Social Dominance: XXXX% [#](/topic/novartis/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/social_dominance.tsv)  
**Current Value**: XXXX%  
**Daily Average**: XXXX%  
**1 Week**: XXXXX% +0.019%  
**1 Month**: XXXXX% +0.032%  
**6 Months**: XXXXX% -XXXX%  
**1 Year**: XXXXX% +0.065%  
**1-Year High**: XXXXX% on 2025-04-11  
**1-Year Low**: XXXXX% on 2025-07-01  
  
  
### Market Dominance: XXXXX% [#](/topic/novartis/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2024-12-16  
  
  
### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/novartis/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXXX +$1.40%  
**1 Month**: $XXXXXXXXXXXXXXX +$7.50%  
**6 Months**: $XXXXXXXXXXXXXXX +$17%  
**1 Year**: $XXXXXXXXXXXXXXX +$7.30%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-10-03  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-19  

**Top assets mentioned**
In the posts about Novartis AG in the last XX hours

[Pfizer, Inc. (PFE)](/topic/$pfe)
[Sanofi (SNY)](/topic/sanofi)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[ROGin AI (ROG)](/topic/$rog)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Novartis AG (NVS)](/topic/$nvs)
[Microsoft Corp. (MSFT)](/topic/microsoft)

**Top topics mentioned**
In the posts about Novartis AG in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$novnsw](/topic/$novnsw), [switzerland](/topic/switzerland), [stocks technology](/topic/stocks-technology), [$novn](/topic/$novn), [$pfe](/topic/$pfe), [sanofi](/topic/sanofi), [stocks](/topic/stocks), [$nesn](/topic/$nesn), [eli lilly](/topic/eli-lilly), [$rog](/topic/$rog), [$azn](/topic/$azn), [$mrk](/topic/$mrk), [$amgn](/topic/$amgn), [$nvs](/topic/$nvs), [microsoft](/topic/microsoft), [ibm](/topic/ibm), [investment](/topic/investment), [$anet](/topic/$anet), [$panw](/topic/$panw), [stocks financial services](/topic/stocks-financial-services), [stocks consumer defensive](/topic/stocks-consumer-defensive), [breast cancer](/topic/breast-cancer), [india](/topic/india), [$abbv](/topic/$abbv), [has been](/topic/has-been), [$trml](/topic/$trml), [johnson johnson](/topic/johnson-johnson), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [iii](/topic/iii), [$googl](/topic/$googl), [stocks communication services](/topic/stocks-communication-services), [$qcom](/topic/$qcom), [$issc](/topic/$issc), [tariffs](/topic/tariffs), [money](/topic/money), [$bud](/topic/$bud), [$abibr](/topic/$abibr), [stocks banks](/topic/stocks-banks), [#ai](/topic/#ai), [$ipnpa](/topic/$ipnpa), [$sdzsw](/topic/$sdzsw), [$uber](/topic/$uber), [south africa](/topic/south-africa), [greece](/topic/greece), [$nvo](/topic/$nvo), [careers](/topic/careers), [future of](/topic/future-of), [$pep](/topic/$pep), [gilead sciences](/topic/gilead-sciences), [ghana](/topic/ghana), [shanghai](/topic/shanghai), [$2607hk](/topic/$2607hk), [drops](/topic/drops), [japan](/topic/japan), [$mngl](/topic/$mngl), [mindset](/topic/mindset), [$ptct](/topic/$ptct), [$legn](/topic/$legn), [$reymi](/topic/$reymi), [hosted](/topic/hosted), [$unh](/topic/$unh), [$baynsg](/topic/$baynsg), [$rhhby](/topic/$rhhby), [goldman sachs](/topic/goldman-sachs), [drugs](/topic/drugs), [taiwan semiconductor](/topic/taiwan-semiconductor), [$torntpharmns](/topic/$torntpharmns), [hub](/topic/hub), [united states](/topic/united-states), [accenture](/topic/accenture), [$bpmc](/topic/$bpmc), [modern warfare](/topic/modern-warfare), [samantha](/topic/samantha), [$6160hk](/topic/$6160hk), [$bgne](/topic/$bgne), [make a](/topic/make-a), [approved](/topic/approved), [jersey](/topic/jersey), [tiktok](/topic/tiktok), [about to](/topic/about-to), [up the](/topic/up-the), [argo app](/topic/argo-app), [coins nft](/topic/coins-nft), [$argo](/topic/$argo), [$deo](/topic/$deo), [$hood](/topic/$hood), [stocks industrials](/topic/stocks-industrials), [$bmy](/topic/$bmy), [$ko](/topic/$ko), [the only](/topic/the-only), [$incy](/topic/$incy), [china](/topic/china), [im a](/topic/im-a), [university of](/topic/university-of), [royal caribbean](/topic/royal-caribbean), [$idya](/topic/$idya), [$ubs](/topic/$ubs), [cnbc](/topic/cnbc), [facebook](/topic/facebook)

### Top News [#](/topic/novartis/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Herpes Simplex Pipeline 2025: MOA and ROA Insights Clinical Trials Status and Key Companies Involved by DelveInsight AiCuris United BioPharma Novartis Maruho Co. Ltd. GlaxoSmithKline - The Globe and Mail"  
[News Link](https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/35468722/herpes-simplex-pipeline-2025-moa-and-roa-insights-clinical-trials-status-and-key-companies-involved-by-delveinsight-aicuris-united-biopharma-novartis-maruho-co-ltd-glaxosmithkline/) [@globeandmail](/creator/x/globeandmail) 2025-10-15T17:10Z 208.1M followers, XXX engagements



### Top Social Posts [#](/topic/novartis/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📢 CALL FOR APPLICATIONS Access state-of-the-art research expertise and technology by applying for the 2026 Next Generation Scientist program a rigorous and immersive training hosted coordially by Novartis and the University of Basel Switzerland. Eligibility: Post-graduate students in LMICs 🔎Areas of interest: Chagas disease cryptosporidiosis dengue leishmaniasis leprosy malaria or sickle cell disease Deadline: 31st October 2025 #NGS2026"  
[X Link](https://x.com/humangeneticstz/status/1979793308911022485) [@humangeneticstz](/creator/x/humangeneticstz) 2025-10-19T06:14Z 3299 followers, XX engagements


"8/In order to maintain its leadership position in this space $NVS has started to use AI to accelerate its supply chain. Novartis is also expanding its manufacturing facilities by adding more sites in the U.S as well as new ones in China & Japan to its existing X manufacturing sites now operating in the U.S and Europe"  
[X Link](https://x.com/yaireinhorn/status/1979766418754150577) [@yaireinhorn](/creator/x/yaireinhorn) 2025-10-19T04:27Z 16.8K followers, XXX engagements


"Switzerland - Weekend Highlights Most Active: - $NESN / Nestle SA - Favourable (+14 Overbought) - $ROG / Roche Holding AG - Neutral (+13 Rangebound) - $NOVN / Novartis AG - Favourable (+20 Trending Higher) - $UBSG / UBS Group AG - Favourable (+16 Oversold) - $ABBN / Abb Ltd - Favourable (+23 Rangebound) Best Darwin Scores: - $EFGN / EFG International AG - Favourable (+38 Trending Lower) - $SDZ / Sandoz Group AG - Favourable (+36 Rangebound) - $SCMN / Swisscom AG - Favourable (+31 Trending Higher) - $CFR / Compagnie Financiere Richemont SA - Favourable (+30 Trending Higher) - $SREN / Swiss Re"  
[X Link](https://x.com/Darwin_Knows/status/1979761278936813630) [@Darwin_Knows](/creator/x/Darwin_Knows) 2025-10-19T04:07Z XXX followers, XXX engagements


"@USDOL Get rid of all H1B and other visas we don't believe anything you say until thats done Thanks ☺ also investigate all the pharmaceutical companies starting with Legend Biotech Novartis BMS Sanofi. They are 💯 abusing this and not hiring American citizens first"  
[X Link](https://x.com/misslucia43/status/1979712341316100163) [@misslucia43](/creator/x/misslucia43) 2025-10-19T00:52Z XX followers, XX engagements